In vivo imaging of transgenic Leishmania parasites in a live host.
about
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous LeishmaniasisA new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imagingThe susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposingLuciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitroNon-invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infectionsAppraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasisHighly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferaseLeukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi.Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugsEvaluation of α,β-unsaturated ketones as antileishmanial agents.Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.Concomitant Immunity Induced by Persistent Leishmania major Does Not Preclude Secondary Re-Infection: Implications for Genetic Exchange, Diversity and Vaccination.Experimental infection of Phlebotomus perniciosus by bioluminescent Leishmania infantum using murine model and artificial feederMetal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cellsIn vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection.Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.Imaging trematode and nematode parasites.Thymol and eugenol derivatives as potential antileishmanial agentsDifferent susceptibilities of Leishmania spp. promastigotes to the Annona muricata acetogenins annonacinone and corossolone, and the Platymiscium floribundum coumarin scoparone.In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.A step beyond BRET: Fluorescence by Unbound Excitation from Luminescence (FUEL).New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney.
P2860
Q26786195-7EF2F003-7835-4D1F-9B2F-68FD29917FC6Q27011506-701EFA56-6A76-4E04-BA21-DB1A951B7D2EQ28476644-5ABC713A-9CD5-44C3-8BAC-29578AF0DC2AQ28477052-9D26E601-BF7B-4A03-97FF-AB936E7168C8Q28484843-E2F00ED7-892B-42B1-9934-584C9FFE0BEFQ28485377-B8007848-261D-47D8-BCA0-C8317BD07303Q28535374-F96693BD-D411-4AF1-BAED-DBACB2466665Q34484497-80EEF311-4C44-4F03-965D-247F66E245F9Q35027309-5012713E-CCAB-469E-9066-39D5C2968E94Q35607871-894A4376-301F-4879-B43C-3EACA35F0834Q35867177-45085983-A7B4-4E16-B16C-8BE5E3FB7779Q36032742-10312942-E7C2-4D59-8C0E-CBA0A72E1B12Q36063251-5988DBEE-5673-4921-9535-038762CFE702Q37167717-FFD572DB-EEA9-4C77-9706-F4A80B22FDADQ37198743-B0E92277-54B5-4E58-A3EE-5723B1E122A6Q37679849-49D155E5-DED2-4E2B-B448-4FD9B7287E19Q37720821-38861923-2E8C-4E98-90AE-ADF46BC5BCECQ38120563-D18BAB82-15D2-4CD1-9F59-7CBEBB7DE428Q38950732-438CC4D8-BFD1-4293-A2F4-F9AB0B2A2BD4Q41894205-BAAC8C81-184A-4271-8096-7C3AADFE4072Q41928242-3B3A9AFE-1A24-4C7A-902E-8E5AEC75D976Q42031523-3924C9C3-C1D3-4E5E-AC00-331A8D5DA77FQ42370906-201BA6EE-7C2A-4800-9C14-E79BA940EE56Q46275091-95019983-1B64-4F0F-87CC-1DBAA4A0623BQ47549359-762FFEC6-C8DC-4345-88FD-198E39F726AE
P2860
In vivo imaging of transgenic Leishmania parasites in a live host.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In vivo imaging of transgenic Leishmania parasites in a live host.
@en
In vivo imaging of transgenic Leishmania parasites in a live host.
@nl
type
label
In vivo imaging of transgenic Leishmania parasites in a live host.
@en
In vivo imaging of transgenic Leishmania parasites in a live host.
@nl
prefLabel
In vivo imaging of transgenic Leishmania parasites in a live host.
@en
In vivo imaging of transgenic Leishmania parasites in a live host.
@nl
P2093
P2860
P356
P1476
In vivo imaging of transgenic Leishmania parasites in a live host.
@en
P2093
Colin J Thalhofer
Joel W Graff
Laurie Love-Homan
Mary E Wilson
Noah Craft
Suzanne M Hickerson
P2860
P356
10.3791/1980
P577
2010-07-27T00:00:00Z